| From Candidate Drug to Clinical PoC: Managing the Continuum |
| AN INTEGRATED SOLUTION IN ACTION. |
Monday, March 23rd 9:15-10:15 AM PT Room 24C Experts in safety, pharmacology,
DMPK, regulatory and clinical strategy discuss approaches to successfully
develop a molecule—from candidate selection to PoC. The session will focus on
drug safety strategy as part of the overall drug development plan, and provide
insights on the importance of scientific and operational continuity to achieve
regulatory milestones. Presented by: Global Vice President, Alliance Management Senior Director, Regulatory Strategy, Global Regulatory Affairs Director, Molecule Management and Business Operations, Molecule Development Group Vice President, Global Lead Safety Pharmacology & Safety Assessment |
FOLLOW US |
 |
 |
    |
 |